fbpx

Massive Bio's multidisciplinary team is has in-depth business and healthcare experience consisting of oncologists, molecular diagnostic scientists, reimbursement experts, and data scientists.

Selin Kurnaz
Selin Kurnaz
Selin Kurnaz, PhD
Lead-founder and CEO

Dr. Kurnaz is an expert in strategy, operations and transactions with a unique, global background that spans across healthcare, academia and consulting. After completing a PhD at the University of Michigan and receiving multiple engineering degrees, Dr. Kurnaz spent more than a decade delivering revenue enhancement, margin optimization and capital efficiency improvements for Pharmaceutical and Life Science companies. Dr. Kurnaz also has measurable success identifying and delivering value to over a dozen investment firms. Most recently, Dr. Kurnaz was with EY's Private Equity Value Creation. Dr. Kurnaz has also written and spoke extensively about improving customer responsiveness in disruptive times.

Arturo Loaiza-Bonilla
Arturo Loaiza-Bonilla
Dr. Arturo Loaiza-Bonilla
Co-founder and Chief Medical Advisor

Dr. Loaiza-Bonilla is an ABIM certified specialist in Medical Oncology, Hematology and Internal Medicine. He has extensive clinical and research experience with a focus in precision oncology and translational-based trials, as well as the multidisciplinary comprehensive care of patients suffering from gastrointestinal and neuroendocrine malignancies. Using evidence-based and patient-centered approaches, Dr. Loaiza-Bonilla integrates next-generation personalized molecular diagnostics, immunotherapy, comorbidity, previous therapies, and the patient's overall status into decision making.

Dr. Loaiza-Bonilla also provides expert second opinions (locally and internationally), clinical trial guidance, as well as recommendations regarding the integration of personalized cancer genomics, biosimilars, pharmacoeconomics and the concomitant use of complementary/integrative medicine. Dr. Loaiza-Bonilla is principal and co-investigator on several Phase I/III cancer clinical trials with an emphasis on new targeted therapies, novel molecules and immunotherapy tailored to specific tumor type, genomic and protein expression profiles. Dr. Loaiza-Bonilla is a passionate advocate for precision oncology, medical education, organized medicine leadership and global health policy. Dr. Loaiza-Bonilla has been awarded the AMA Foundation Leadership Award and the Fellowship of the American College of Physicians. In addition, Dr. Loaiza-Bonilla holds a Master in Medical Education (M.S.Ed) degree from the University of Pennsylvania.

Harry M. Buchman
Harry M. Buchman
Harry M. Buchman
Chief Business Officer

Harry M. Buchman serves as an operations consultant for Massive Bio. His primary focus is on ensuring the organization meets and exceeds the expectations of each patient and organization that contacts Massive Bio. He earned a Bachelors in Administration of Justice from Pennsylvania State University and a Masters of Business Administration in healthcare administration and finance from Loyola University Chicago. He also obtained his Lean Six Sigma Greenbelt certification through the University of Michigan. Prior to joining the team at Massive Bio, Mr. Buchman most recently was the administrator for the oncology program at St. Mary Medical Center, a member of Trinity Health. Before then, over a 15-year period, he served multiple roles within Cancer Treatment Centers of America® (CTCA), where he most recently held the position as Assistant Vice President of Patient Experience at Eastern Regional Medical Center in Philadelphia. He also held positions at an executive recruiting firm in Delray, Florida, where he recruited high-level executive positions for Fortune 50 companies and MBNA America in State College, Pennsylvania, where he managed, trained, and mentored the company’s top sales team.

Belisario Arango
Belisario Arango
Dr. Belisario A. Arango
Chief of Community Oncology

Dr. Belisario A. Arango is the medical director of the Cancer Center and the Coagulation/Thrombosis Clinic at Chippewa County War Memorial Hospital and is affiliated with Helen Newberry Joy Hospital and Mackinac Straits Hospital and Health Center. In addition, Dr. Arango serves as director of the Continuing Medical Education for providers at War Memorial Hospital. As a solo practitioner, Dr. Arango specializes in providing both hematology and medical oncology care for the majority of patients who reside in the Eastern Upper Peninsula of Michigan.

Prior to completing his internal medicine residency and hematology/oncology fellowship, Dr. Arango completed 2 years of medical oncology research at The University of Miami Sylvester Comprehensive Care Center/Jackson Memorial Hospital with a focus on genitourinary malignancies and sarcomas. Dr. Arango has authored multiple articles in peer-reviewed journals and has presented at international medical oncology conferences.  Dr. Arango practices evidence-based medicine and believes that cancer care requires a multi-disciplinary team approach. In an era of rapid developments in cancer care knowledge, Dr. Arango has been instrumental in bringing precision medical oncology care to patients at community hospitals that was otherwise inaccessible to them unless they were evaluated at a tertiary institution. Dr. Arango’s philosophy is to take care of cancer patients as if they were his own family members. He goes above and beyond what is necessary to deliver optimal and state of the art cancer care for his patients by utilizing medical technology and collaborating with different institutions in the region.

Jason Freedman
Jason Freedman
Dr. Jason L. Freedman
Chief Pediatric Advisor

Jason Freedman, MD, MSCE is a Board Certified Pediatric Oncologist who graduated with honors from Cornell University and received his medical degree Magna Cum Laude from Upstate Medical University in Syracuse, NY. Dr. Freedman completed his residency in Pediatrics at the Children’s Hospital of NY-Presbyterian (Columbia University) and served as Pediatric Chief Resident, thereafter. He completed fellowship training in Pediatric Hematology/Oncology at Children’s Hospital of Philadelphia (CHOP), during which time he earned a Master’s of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania.  Dr. Freedman has received numerous awards and honors including induction into the Alpha Omega Alpha medical honor society, and nominations into the President’s Circle of Excellence and Attending of the Year at the Children’s Hospital of NY-Presbyterian. During fellowship at The Children’s Hospital of Philadelphia, he was the recipient of the William Potash Fellow Teacher of the Year for his commitment to resident education and clinical excellence. As a faculty member at PENN/CHOP, he has earned a Distinguished Teaching Award and was selected for the early career faculty honor roll.  Dr. Freedman is an attending physician in Oncology at CHOP, where he also has administrative and teaching responsibilities. Dr. Freedman’s clinical focus is blood and marrow transplantation and hematologic malignancies. He has a particular interest in quality improvement and supportive care, and serves on several national committees. Dr. Freedman has authored several textbook chapters and peer-reviewed articles on the care of children with cancer and has contributed to the development of clinical guidelines to standardize management of symptoms associated with cancer therapy.

Cagatay M. Culcuoglu
Cagatay M. Culcuoglu
Cagatay M. Culcuoglu, MBA
Co-founder, Chief Operating Officer & Chief Technology Officer

Mr. Culcuoglu leads operational strategy, global business initiatives, product and technology development at Massive Bio. Mr. Culcuoglu has developed several products over the past 20 years, primarily for the financial, media and health industry. A serial entrepreneur, Mr. Culcuoglu co-founded startups, where he also led business and sales operations as well technology and product development. Mr. Culcuoglu took senior roles at Thomson Reuters, Mubasher, KPMG, Sabrient Systems, Anadolu Agency, Merrill Lynch and Smeal College. Mr. Culcuoglu is an active board member in multiple start-ups and an owner of a media company. In addition, Mr. Culcuoglu holds an MBA degree from Pennsylvania State University and MA degree from University of Maastricht.

Joshua Hecht
Joshua Hecht
Joshua Hecht
Chief Financial Officer

Mr. Hecht is Massive Bio's Chief Financial Officer and co-founder of multiple companies. He has extensive experience working with high-growth startups on entrepreneurial finance matters, including capital markets, incentives, and governance. An accomplished entrepreneur, executive, and advisor, Joshua has played an integral role in building many technology-focused businesses and working with some of the largest companies in the world on high-profile M&A transactions. He holds a BA from Cornell University and an MBA from Columbia Business School.